The federal Project Grant award of $799,440 was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The purpose of the award is to increase the number of paramedics, enhance training for opioid overdoses, and increase proficiency in substance use disorders training for the local Emergency Medical Services (EMS) force. Specific activities...
This Project Grant award of $850,000 was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The funding supports the Oneida Nation Tribal Opioid Response Project, a culturally-based, trauma-informed prevention service aimed at addressing the opioid crisis in the Oneida community. Key services include traditional substance abuse counseling,...
The Oregon Health Authority (OHA) was awarded a $45,830,769 Project Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The 3-year grant, with an end date of September 29, 2027, will focus on expanding substance use prevention, overdose prevention, harm reduction, treatment access, recovery support services, and workforce development in...
This $168,406,482 Project Grant, awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243), funds the NYS OASAS SOR 4 initiative. This initiative continues the Regional Network Approach to provide prevention, harm reduction, treatment, and recovery services for New York State residents with opioid use disorder (OUD), stimulant use disorder (STUD), or...
This $2,570,500 project grant from the Department of Health and Human Services Health Resources and Services Administration supports the development and operation of an integrated substance use disorder training program. Funded under the Mental and Behavioral Health Education and Training Grants program (CFDA 93.732), the award supports a consortium approach to establish a post-graduate training program for nurse practitioners and physician assistants. The program will provide training for these...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $37,611,000 Project Grant (CFDA 93.243 - Substance Abuse and Mental Health Services Projects of Regional and National Significance) to the Puerto Rico Mental Health and Anti-Addiction Services Administration (MHAASA) for a 3-year "Puerto Rico State Opioid Response 2024" project. The project aims to implement a comprehensive strategy to address opioid use in Puerto Rico through evidence-based prevention,...
This $341,268 Project Grant awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) will support the Karuk Tribe's efforts to address the opioid overdose crisis in its tribal communities. The funding will be used to increase access to FDA-approved medications for opioid use disorder (OUD) treatment, provide a sober transitional recovery home for...
The Government of the District of Columbia received a $75,500,157 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Opioid State Targeted Response (Opioid STR) program (CFDA 93.788). The grant, known as the District of Columbia's Opioid Response 4 (DCOR 4) initiative, aims to address the opioid overdose crisis by increasing access to Medication for Opioid Use Disorder (MOUD), reducing unmet treatment needs, and decreasing opioid...
This $13,032,060 Project Grant award from the Substance Abuse and Mental Health Services Administration's (SAMHSA) Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program will support the implementation of evidence-based prevention, treatment, and recovery strategies for individuals with opioid and/or stimulant use disorders in Montana. Key strategies include developing a mobile medication-assisted treatment (MOUD) unit, expanding...
This federal Project Grant award of $599,120 was provided by the U.S. Department of Health and Human Services (HHS) Health Resources and Services Administration (HRSA) under the Mental and Behavioral Health Education and Training Grants program (CFDA 93.732). The grant supports the development and expansion of the behavioral health workforce, particularly in serving children, adolescents, young adults, and communities impacted by opioid use disorders. The grant recipient, The Research Foundation...
This federal Project Grant award of $55,500,000, provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, supports the Opioid Response Network (ORN).
The ORN, led by a coalition of 50 national and regional healthcare organizations including the American Academy of Addiction Psychiatry, the University of Missouri-Kansas City, and Columbia University, delivers training and technical assistance (TTA) to address opioid use disorder, stimulant use disorder, other substance use disorders, and co-occurring psychiatric disorders across all 50 states and 9 territories. The ORN aims to increase outreach to underserved communities, build workforce capacity to address health disparities, increase culturally relevant evidence-based services, reduce stigma, and maximize the impact and sustainability of SAMHSA's TTA resources. The grant period runs from September 30, 2024 to September 29, 2027, during which the ORN plans to serve 135,000 unduplicated individuals annually.